トルコのトップ分子標的治療医師と価格を比較。こちらで最適なマッチングを見つけてください
ご要望と予算に基づいて最適な医師を厳選いたします
医学的監修者 Fahad Mawlood
医学編集者・データサイエンティストトップ医師
13
トルコ
レビュー
14000+
実際の患者より
トップ各国の分子標的治療価格を比較
国をタップしてトップ医師と価格を表示
最も人気の範囲
$1.5K
$3K
$4.5K
$6K+
$7.5K+
$9K+
$10.5K+
$12K+
$1,500 – $4,900
ほとんどの患者がこの範囲内でお支払いです
正確な費用は選択された医師、技術、治療部位、お客様の個別ニーズによって決まります
お客様のケースに正確な見積もりを取得
個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし
最初に表示：
141名の方が先月見積もりをリクエストしました
標的療法およびがん免疫療法を専門とし、Karagöz医師はアナドル医療センターにて33年の経験の腫瘍学臨床経験を有しています。
55名の方が先月見積もりをリクエストしました
エダ・タンリクル医師は、アナドル医療センターにて腫瘍内科および化学療法を専門とし、トルコの腫瘍内科専門医試験において第3位の成績を収めています。
32名の方が先月見積もりをリクエストしました
Solak医師は、ハジェテペ大学がん研究所およびMDアンダーソンがんセンターで研鑽を積み、各種がんの分子標的療法を専門としています。
44名の方が先月見積もりをリクエストしました
シナン・カラアスラン博士は、乳がん、大腸がん、泌尿生殖器系がんの管理において最高の腫瘍医の一人です。
32名の方が先月見積もりをリクエストしました
トルコ医療腫瘍学専門試験第1位 – ケスキン医師はメモリアル・シシリ病院にて分子標的療法を専門としています。
イェシム・ユルドゥルム教授は、がん免疫療法および分子標的療法を専門とし、80本以上の論文を発表するとともに、主要な腫瘍学ハンドブックの共著者でもある。
Şeref Kömürcü教授は、ECFMGおよびESMO認定の医療および乳腺腫瘍学者であり、トルコを拠点に20年以上の実践経験を持っています。硬癌、乳癌、大腸癌、肺癌の治療を専門としています。
癌管理に関する110を超える論文を書いています。
この医師は、トルコのいくつかの著名な病院で豊富な経験を持つベテランの医療腫瘍学者であり、2019年からMemorial Bahçelievler Hospitalに勤務しています。Cerrahpasa Faculty of Medicineで医学の学位を取得し、Sisli Etfal Training and Research Hospitalで内科のレジデンシーを修了し、Istanbul Bilim Universityで医療腫瘍学のレジデンシーを修了しました。2016年に准教授の地位を達成し、医療腫瘍学の分野で20以上の論文と10の書籍の章を執筆しています。
2012年にトルコ医療腫瘍学会から腫瘍研究賞を受賞し、ヨーロッパ医療腫瘍学会を含む複数の専門学会の積極的なメンバーです。
Education and Expertise
Selcuk University Meram Faculty of Medicine - Medical Education
Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization
Experience
Malatya State Hospital Internal Diseases Clinic
Ankara Oncology Hospital Medical Oncology Clinic
Erzurum Regional Training and Research Hospital Medical Oncology Clinic
AREAS OF INTEREST
Lung cancer
esophageal cancer
Gastric cancer
breast cancer
Gastrointestinal surgery
https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr
この医師は、乳がん、肺がん、消化器系がんの治療を専門とする腫瘍学者です。現在、医師はIstinye Liv University Hospitalで診療を行っています。<\/p>
多くの著名な機関でのキャリアを持ち、医師はMalatya State Hospitalで内科専門医として、Ankara Oncology Clinicで医師として、Erzurum Regional Training and Research Hospitalの腫瘍学部門のメンバーとして勤務してきました。<\/p>
医師はSelcuk Universityの医学部を卒業し、2016年に准教授の称号を取得しました。<\/p>
Dr. Cagdas Erdogan is a gastroenterologist at Ankara Etlik City Hospital. He trained in Internal Medicine and Gastroenterology. He earned his MD from Dokuz Eylul University. He completed his Internal Medicine residency from 2014 to 2019. He then completed a Gastroenterology fellowship at Ankara City Hospital from 2019 to 2022. His clinical focus includes advanced endoscopy (ERCP, EUS, EMR, ESD, POEM, EGD, colonoscopy, double-balloon enteroscopy), inflammatory bowel disease, and hepatology.
He has about 40 publications. His work appears in The Turkish Journal of Gastroenterology, Scientific Reports, Endoscopy, and Digestive Diseases and Sciences. Notable studies address vedolizumab in IBD and prophylaxis for post-ERCP pancreatitis. He also reported a 13-year Crohn’s cohort comparing infliximab and adalimumab. Additional work covers outcomes with an adalimumab biosimilar and innovative endoscopic therapies (MCA via double-balloon enteroscopy, holmium laser for Bouveret syndrome, POEM for Zenker’s diverticulum, and ESD for esophageal papillomatosis).
海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。
ヤン・マツィイフスキー
医療コーディネーターチーム責任者
4300+件以上の患者の旅をガイド
Bookimedで3年
Turkeyの278名の患者が今月当社を通じて医師を見つけました
2分のクイズ
目標、予算、スケジュールをお聞かせください
人間のマッチング + AI
アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します
オプション準備完了
価格、パッケージ、日程を比較。コーディネーターとチャット
選択肢に迷っていますか？
治療をガイド
医療訓練を受けた専属コーディネーター
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 33年の経験 | 分子標的治療薬 | 腫瘍免疫学および分子標的治療を専門とし、個別化がん治療において中心的な役割を担う。腫瘍学の教授職を有し、多数の研究論文を発表している。 | トルコ | から $215 | |
| #2 | 21年の経験 | 分子標的療法 | トルコトップクラスの腫瘍専門医として評価されており、分子標的療法に特化した専門的なトレーニングを受けている。進行がん治療における国際的な臨床研究を主導している。 | トルコ | から $215 | |
| #3 | 20年の経験 | 乳癌および消化器癌 | ハジェテペ大学がん研究所およびMDアンダーソンがんセンターで研修を積んだ分子標的治療の専門家であり、複雑な症例に対する個別化治療計画の立案を専門とする。 | トルコ | から $100 | |
| #4 | 25年の経験 | 高度ながん治療 | トルコで全国的な賞を受賞した最高位の腫瘍専門医。分子標的療法および免疫療法を専門とする。ASCOおよびESMOの現役会員。 | トルコ | から $150 | |
| #5 | 22年の経験 | 免疫療法および分子標的療法 | 最先端のがん治療を専門とし、幅広い研究実績を有する。ESMO認定を取得し、マウント・バーノンをはじめとする国際的な主要医療機関で研鑽を積んだ。 | トルコ | から $215 |
Targeted therapy doctors in Turkey maintain high standards through international certifications and clinical training. Leading specialists hold European Society for Medical Oncology (ESMO) certification. Many experts completed fellowships at global institutions like the MD Anderson Cancer Center. Their practice follows evidence-based protocols established by ASCO and ESMO benchmarks.
Bookimed Expert Insight: Data shows that top Turkish oncologists often merge clinical research with practice. For instance, Dr. Bulent Karagoz and Dr. Seref Komurcu have each published over 40 to 110 research papers. This academic focus means patients receive treatments based on the latest tumor biology findings. Many leading doctors hold professor titles and lead oncology departments at major university hospitals.
Patient Consensus: Patients note that doctors at major clinics follow Western protocols very closely. Some were surprised by how thoroughly doctors explained the connection between genetic mutations and specific drugs. Many found that having a translator present helped them understand complex treatment steps during their stay.
Medical oncologists and hematologists primarily administer targeted therapies in Turkey. These specialists use precision drugs like monoclonal antibodies to treat solid tumors and blood cancers. Board-certified experts at JCI-accredited centers often hold European Society for Medical Oncology (ESMO) certification for advanced cancer care.
Bookimed Expert Insight: Many Turkish oncologists, like Dr. Serkan Keskin and Dr. Eda Tanrikulu, consistently rank at the top of national proficiency exams. Dr. Keskin ranked 1st in the Medical Oncology Proficiency Exam, while Dr. Tanrikulu ranked 3rd nationwide. This competitive academic landscape ensures that patients receive care from doctors with exceptionally deep theoretical and clinical knowledge.
Patient Consensus: Patients note that medical oncologists serve as their main coordinators throughout the treatment process. They often feel relieved by the lower costs of drug administration compared to North America. Many emphasize that confirming a facility's genetic testing capabilities is a vital step before starting therapy.
Targeted therapy doctors in Turkey speak English fluently as many hold international certifications and completed advanced training abroad. Major private networks recruit bilingual specialists to serve international patients. These oncologists often hold ECFMG or ESMO certifications and maintain memberships in global organizations like ASCO.
Bookimed Expert Insight: Data shows a strong correlation between English fluency and specific hospital affiliations. Doctors at Anadolu Medical Center, such as Dr. Bulent Karagoz and Dr. Seref Komurcu, work within a Johns Hopkins Medicine alliance. This partnership requires frequent professional exchange in English, ensuring high communication standards during complex tumor board reviews.
Patient Consensus: Patients note that while lead specialists speak English well, technical details can sometimes be lost with support staff. Many suggest using a translation app for quick chats with nurses. Those who booked through coordinators felt more confident during deep medical discussions.
Turkish oncologists determine eligibility for targeted therapy through comprehensive genomic profiling and multidisciplinary tumor board reviews. They use next-generation sequencing to identify driver mutations like EGFR, ALK, or BRAF. Doctors confirm these actionable targets to match patients with specific precision drugs.
Bookimed Expert Insight: Turkish oncology centers often perform complex genomic testing in-house. This allows specialists like Dr. Bulent Karagoz at Anadolu Medical Center to receive results within 14 days. This speed is critical for patients with aggressive tumors needing rapid treatment changes. Dr. Yesim Yildirim, an ESMO-certified professor, frequently utilizes international clinical study data to personalize these choices for her patients.
Patient Consensus: Patients note that bringing previous biopsy results and imaging can speed up the eligibility process. Many felt reassured when tumor boards collectively reviewed their cases to confirm the best drug match. They also found the 24/7 coordinator support helpful for navigating fast-tracked diagnostic testing schedules.
International patients can consult with targeted therapy doctors in Turkey remotely through secure telehealth platforms. Leading oncologists use video consultations to review genomic profiles and medical records. These virtual sessions help determine personalized drug protocols before patients travel for treatment.
Bookimed Expert Insight: Data shows that top Turkish oncologists like Dr. Yesim Yildirim and Dr. Bulent Karagoz have international training from centers like Mount Vernon in London. These professors often offer consultations starting from $215 at Anadolu Medical Center. This center is unique because it maintains a formal partnership with Johns Hopkins Medicine. Patients can access this specific US-affiliated expertise via remote calls at a fraction of Western costs.
Patient Consensus: Patients note that Turkish oncologists are often more open to discussing off-label drug combinations during calls. Many felt relieved to receive a personalized plan within days through WhatsApp or Zoom. They found the quick response times helped them avoid long waiting lists in their home countries.
Foreign doctors may legally practice oncology and targeted therapy in Turkey within private medical centers. Law No. 1219 allows foreign-trained physicians to work after obtaining diploma equivalency and ministry approval. These specialists must hold a Turkish language certificate and practice exclusively in the private healthcare sector.
Bookimed Expert Insight: While foreign doctors practice in Turkey, many leading Turkish oncologists possess significant international training. Dr. Yesim Yildirim at Anadolu Medical Center trained in London and Haifa, while Dr. Mustafa Solak worked at the MD Anderson Cancer Center. This creates a medical environment where local surgeons apply global standards and offer consultations starting from $100.
Patient Consensus: Patients note that international specialists often work in private facilities under strict local board oversight. Some visitors mention that treatment steps like targeted drug prescriptions might require a local doctor's co-signature. People feel more confident when clinics provide 24/7 support and help navigating these specific medical regulations.